首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Development and cross-sectional validation of the Childhood Asthma Control Test.
【24h】

Development and cross-sectional validation of the Childhood Asthma Control Test.

机译:儿童哮喘控制测试的开发和横断面验证。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: For children younger than 12 years old with asthma, there are several quality-of-life instruments, clinical diaries, and questionnaires assessing symptoms; however, a validated tool for assessing asthma control is currently lacking. OBJECTIVE: To develop and validate the Childhood Asthma Control Test (C-ACT), a self-administered tool for identifying children aged 4-11 years whose asthma is inadequately controlled. METHODS: A 21-item questionnaire was administered to 343 patients with asthma and their caregivers, randomly assigning 75% (n = 257) for development and cross-sectional validation of the tool and 25% (n = 86) to a confirmatory sample. Stepwise logistic regression was used to reduce the 21 items to those best able to discriminate control as defined by the specialist's rating of asthma control. RESULTS: Seven items were selected from regression analyses of the development sample to comprise the C-ACT. The scores of each item were summed for a total score (0-27), with lower scores indicating poorer control. Summed scores discriminated between groups of patients differing in the specialists' rating of asthma control (F = 36.89; P < .0001), the need for change in patients' therapy (F = 20.07; P < .0001), and % predicted FEV(1) (F = 2.66; P = .0494). A score of 19 indicated inadequately controlled asthma (specificity 74%, sensitivity 68%). These analyses were confirmed in the confirmatory sample. CONCLUSION: The C-ACT is a validated tool to assess asthma control and identify children with inadequately controlled asthma. CLINICAL IMPLICATIONS: The C-ACT can be valuable in clinical practice and research based on its validation, ease of use, input from the child and caregiver, and alignment with asthma guidelines.
机译:背景:对于12岁以下患有哮喘的儿童,有几种生活质量的仪器,临床日记和评估症状的问卷;然而,目前缺乏用于评估哮喘控制的经过验证的工具。目的:开发和验证儿童哮喘控制测试(C-ACT),这是一种自我管理的工具,用于识别4-11岁哮喘未得到充分控制的儿童。方法:向343名哮喘患者及其护理人员进行了21项问卷调查,随机分配了75%(n = 257)进行工具开发和横断面验证,将25%(n = 86)用作确认性样本。采用逐步逻辑回归将21项减少到最能区分哮喘的那些,这是由专家对哮喘控制的评估所定义的。结果:从发展样本的回归分析中选择了七个项目,以构成C-ACT。将每个项目的分数相加,得出总分数(0-27),分数越低表示控制效果越差。不同组的患者的总得分之间存在差异,这些患者的哮喘控制专家评分不同(F = 36.89; P <.0001),需要改变患者的治疗方法(F = 20.07; P <.0001)和预测的FEV% (1)(F = 2.66; P = .0494)。 19分表示哮喘控制不充分(特异性74%,敏感性68%)。这些分析在确认性样品中得到确认。结论:C-ACT是评估哮喘控制和识别哮喘控制不足的儿童的有效工具。临床意义:基于C-ACT的有效性,易用性,儿童和照料者的意见以及与哮喘指南的一致性,C-ACT在临床实践和研究中可能有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号